[62] Some strains of rotavirus use their NSP1 protein to cause IRF7 degradation via the proteasome, whereas other strains target IRF3, IRF5 or β-transducin repeat-containing protein (β-TrCP), a component of the E3 ubiquitin ligase complex that activates NF-κB.[63] Finally, the ebolavirus VP35 protein represents an interesting example of IRF7 inhibition: in macrophages and conventional DCs, VP35 interferes with IRF7

activation via the RLR pathway, whereas in plasmacytoid DCs, VP35 does not block IFN production, because this Z-VAD-FMK research buy cell type activates IRF7 through the TLR pathway.[64] Hence, non-redundant IFN induction pathways can help an organism to counteract specific virus evasion mechanisms. Viruses can also impair ICG-001 ic50 IFN gene expression by inducing a general disruption of host cell transcription. The NSs protein from La Crosse encephalitis virus does just this, exploiting specific components of the DNA-damage response to cause the proteasomal degradation of the hyperphosphorylated form of RPB1, a component of cellular RNA polymerase II (RNAP II), allowing it to

selectively silence elongating RNAP II complexes. This does not impede the virus itself, as RNAP II is not required for the transcription or replication of the La Crosse encephalitis virus genome.[65] The second step of the biphasic IFN response, where secreted IFN binds its receptor (IFNAR) and activates ISG induction, is also actively disrupted by viruses. Although the exact mechanism is unknown, ORF54, a functional dUTPase from murine γ-herpesvirus-68, causes the degradation of the IFNAR1 protein, even in the absence of dUTPase enzymatic activity.[66] Several other viruses indirectly

target IFNAR, by activating alternative signalling. For instance, HCV induces the Ras/Raf/MEK pathway, which increases the phosphorylation of a destruction motif in the cytoplasmic tail of IFNAR1, leading to its ubiquitin-dependent endocytosis.[67] The Kunjin strain of West Nile virus may employ a similar strategy, as the viral proteins NS4A and NS4B block IFN signalling by stimulating the unfolded protein response,[68] possibly Casein kinase 1 via IFNAR degradation.[69] Interferon binding to IFNAR activates the Janus family protein kinases (JAKs) Tyk2 and Jak1, inducing site-specific phosphorylation of tyrosine residues in signal transducers and activation of transcription 1 (STAT1) and STAT2, leading to their activation and formation of a heterotrimeric complex containing IRF9, known as IFN-stimulated gene factor-3 (ISGF3) (Fig. 3).[70] Each stage of the JAK/STAT signalling pathway is disrupted by viral proteins. Human metapneumovirus reduces Jak1 and Tyk2 mRNAs and proteins,[71] leading to decreased IFNAR cell surface expression by way of increased internalization but not degradation, possibly through the loss of Tyk2.